Method for treating atherosclerosis employing an aP2 inhibitor and combination
US7358254B2 · kind B2 · utility
11Cited by
12References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 21, 2004 |
| Grant date | Apr 15, 2008 |
| Priority date | — |
| Expiry date | Jan 21, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method is provided for treating atherosclerosis and related diseases, employing an aP2 inhibitor or a combination of an aP2 inhibitor and another antiatherosclerotic agent, for example, an HMG CoA reductase inhibitor such as pravastatin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.